课题基金 / 基金详情

How MERS-CoV Regulates Innate Immunity in Primary Human Lung Cells

How MERS-CoV Regulates Innate Immunity in Primary Human Lung Cells
MERS-CoV 如何调节原代人肺细胞的先天免疫
批准号:
9809270
负责人:
AMY C SIMS
金额:
$19.44万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-06-05 至 2021-05-31

项目摘要

项目成果

AMY C SIMS的其他基金

相似基金

相关文献

中文摘要
翻译
摘要
英文摘要
ABSTRACT The molecular mechanisms regulating emerging highly pathogenic human respiratory coronavirus pathogenesis are complex and include dampening of the host innate immune response allowing higher viral titers immediately following entry. Previous studies tracking the expression of interferon stimulated gene (ISG) expression in Middle East respiratory syndrome coronavirus (MERS-CoV) infected continuous human lung epithelial cells demonstrated that specific ISG expression patterns could be detected and these patterns could be used to determine how CoV were modulating the innate immune response. Epigenetic/chromatin remodeling mechanisms were found to be important regulators of host chromatin remodeling that altered host expression ISG patterns. This proposal will build on these foundational studies performed in continuous human lung cell lines and define ways that MERS-CoV regulates innate immunity in primary human lung fibroblasts and microvascular endothelial cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
How MERS-CoV Regulates Immunity in Human Lung Tissue
Targeted Gene Expression from NL63 Vaccine Vectors
Human Coronaviruses as Multigene Mucosal Vaccine Vectors for HIV
Targeted Gene Expression from NL63 Vaccine Vectors
海外基金